Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose control and BMI in adults with type 2 diabetes. This study aims to look at how well the medication works in people with type 1 diabetes. Semaglutide is not approved by the FDA to be used in this way.
Sponsor: University of Colorado, Denver
Check if you qualify for this type 1 diabetes clinical trial in Seattle, WA
If you're searching for type 1 diabetes treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.